Cohort studies of a Caucasian population demonstrated that the prevalence of IL6-174C variant was higher in NASH than NAFLD patients, and was associated with increased insulin resistance (Carulli et al., 2009). The gene discussed is IL6; the disease is metabolic dysfunction-associated steatotic liver disease.